Literature DB >> 7577488

A Scottish national mortality study assessing cause of death, quality of and variation in management of patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.

G C Howard1, K Clarke, M H Elia, A W Hutcheon, S B Kaye, P M Windsor, H M Yosef, L Sharp.   

Abstract

A detailed casenote review was performed on 55 patients registered with testicular non-seminomatous germ cell tumours (NSGCT) between 1983 and 1988 under the Scottish Cancer Registration Scheme and who had died by 1992. Details of all aspects of clinical management relating to their NSGCT and death details were extracted and summarised. An assessment was made on whether the patients' management had been optimal. An analysis of 5 year survival rates by the five Scottish oncology centres demonstrated significant differences between centres (range 70.4-94.2; chi 2 = 14.46, d.f. = 4, P = 0.006). Some patients in all centres were assessed as having received suboptimal treatment, but two centres performed less well than the other three. There is a suggestion that the number of patients treated suboptimally decreases with increasing number of patients seen, but this does not reach statistical significance.

Entities:  

Mesh:

Year:  1995        PMID: 7577488      PMCID: PMC2033944          DOI: 10.1038/bjc.1995.506

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  The role of surgery in the combined management of metastases from malignant teratomas of testis.

Authors:  W F Hendry; P Goldstraw; M J Peckham
Journal:  Br J Urol       Date:  1987-04

2.  Management of malignant teratoma: does referral to a specialist unit matter?

Authors:  M J Harding; J Paul; C R Gillis; S B Kaye
Journal:  Lancet       Date:  1993-04-17       Impact factor: 79.321

3.  Surgery following chemotherapy for metastatic testicular teratoma.

Authors:  D Whillis; R E Coleman; A M Lessells; T B Hargreave; M A Cornbleet; G C Howard
Journal:  Br J Urol       Date:  1991-09

4.  The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party.

Authors:  G M Mead; S P Stenning; M C Parkinson; A Horwich; S D Fossa; P M Wilkinson; S B Kaye; E S Newlands; P A Cook
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

5.  Combined management of malignant teratoma of the testis.

Authors:  M J Peckham; T J McElwain; A Barrett; W F Hendry
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

6.  Surgical salvage of advanced testicular tumours.

Authors:  R Ewing; J W Hetherington; W G Jones; R E Williams
Journal:  Br J Urol       Date:  1987-01

7.  Referral patterns within Scotland to specialist oncology centres for patients with testicular germ cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.

Authors:  K Clarke; G C Howard; M H Elia; A W Hutcheon; S B Kaye; P M Windsor; H M Yosef
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

8.  Centralised treatment, entry to trials and survival.

Authors:  C A Stiller
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

Review 9.  A Scottish national audit of current patterns of management for patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Committee of the Royal College of Radiologists.

Authors:  G C Howard; K Clarke; M H Elia; A W Hutcheon; S B Kaye; P M Windsor
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  9 in total
  4 in total

Review 1.  [Interdisciplinary cooperation in the treatment of complex patients with advanced testicular germ cell tumor].

Authors:  A Heidenreich; S Krege; M Flasshove
Journal:  Urologe A       Date:  2004-12       Impact factor: 0.639

2.  Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.

Authors:  A Gerl; C Clemm; N Schmeller; R Hartenstein; R Lamerz; W Wilmanns
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

3.  Access to specialist cancer care: is it equitable?

Authors:  E Pitchforth; E Russell; M Van der Pol
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

4.  Referral patterns within Scotland to specialist oncology centres for patients with testicular germ cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.

Authors:  K Clarke; G C Howard; M H Elia; A W Hutcheon; S B Kaye; P M Windsor; H M Yosef
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.